County
Muskogee County EMS
Muskogee County EMS (Muskogee, OK) carries 42 drugs across 170 dose entries in its current published protocol, effective 2026-01-01.
Drugs and doses42
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | page 107 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 107 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 12 mg | not captured | not captured | standing | page 68 |
| SVT | peds | 0.1–0.2 mg/kg | not captured | not captured | standing | page 68 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 5 mg | NEB | not captured | standing | page 111 |
| Allergic reaction | peds | 2.5 mg | NEB | not captured | standing | page 111 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 265 |
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 90 |
| Asthma / bronchospasm | peds | 1.5 mg | NEB | not captured | standing | page 265 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 90 |
| COPD | adult | 5 mg | NEB | not captured | standing | page 111 |
| COPD | peds | 2.5 mg | NEB | not captured | standing | page 111 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 67 |
| SVT | adult | 150 mg | IV | not captured | standing | page 68 |
| SVT | peds | 5 mg/kg | IV | not captured | standing | page 68 |
| VF / pulseless VT | adult | 300 mg | IV | not captured | standing | page 64 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | page 64 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 162–324 mg | PO | not captured | standing | page 52 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | not captured | not captured | standing | page 54 |
| Bradycardia | peds | 0.02 mg/kg | not captured | not captured | standing | page 54 |
| Organophosphate poisoning | adult | 2–5 mg | IO/IM | not captured | standing | page 109 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IO/IM | not captured | standing | page 109 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 10 mg/kg | IO | not captured | standing | page 270 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 10 mg/kg | IO | not captured | standing | page 270 |
| Hyperkalemia | adult | 10 mg/kg | IO | not captured | standing | page 59 |
| Hyperkalemia | peds | 10 mg/kg | IO | not captured | standing | page 59 |
| Other | adult | 10 mg/kg | IO | not captured | standing | page 109 |
| Other | peds | 10 mg/kg | IO | not captured | standing | page 109 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 10 mg/kg | IV/IO | not captured | standing | page 270 |
| Hyperkalemia | adult | 10 mg/kg | IV/IO | not captured | standing | page 270 |
Clonidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg | PO | not captured | standing | page 96 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 105 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | standing | page 93 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 93 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IO/IM | not captured | standing | page 109 |
| Post-intubation sedation | adult | 1–5 mg | not captured | not captured | standing | page 275 |
| Seizure | adult | 2–5 mg | not captured | not captured | standing | page 113 |
| Seizure | peds | 0.1–0.3 mg/kg | not captured | not captured | standing | page 113 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 276 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IO | not captured | standing | page 68 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IO/IM | not captured | standing | page 90 |
| Allergic reaction | peds | 1 mg/kg | IO/IM | not captured | standing | page 90 |
| Anaphylaxis | adult | 25–50 mg | IO/IM | not captured | standing | page 90 |
| Anaphylaxis | peds | 1 mg/kg | IO/IM | not captured | standing | page 90 |
| Dystonic reaction | adult | 25–50 mg | IO/IM | not captured | standing | page 109 |
| Dystonic reaction | peds | 1–2 mg/kg | IO/IM | not captured | standing | page 109 |
| Nausea / vomiting | adult | 25–50 mg | IO/IM | not captured | standing | page 88 |
| Nausea / vomiting | peds | 1 mg/kg | IO/IM | not captured | standing | page 88 |
| Other | adult | 25–50 mg | IO/IM | not captured | standing | page 207 |
| Other | peds | 1 mg/kg | IO/IM | not captured | standing | page 207 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 54 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 11 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 89 |
| Anaphylaxis | adult | 0.3 mg | IV/IO | not captured | standing | page 91 |
| Anaphylaxis | peds | 0.1 mg | IV/IO | not captured | standing | page 91 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 89 |
| Asthma / bronchospasm | adult | 0.5 mg | IM | not captured | standing | page 112 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 112 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 55 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 56 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 56 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 287 |
| Procedural sedation | peds | 0.2–0.6 mg/kg | IV/IO | not captured | standing | page 287 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 39 |
| RSI induction | peds | 0.2–0.6 mg/kg | IV/IO | not captured | standing | page 39 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.5 mcg/kg | IV/IO/IM/IN | not captured | standing | page 53 |
| Other | adult | 2–3 mcg/kg | IV/IO | not captured | standing | page 39 |
| Other | peds | 2–3 mcg/kg | IV/IO | not captured | standing | page 39 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 172 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 172 |
| Post-intubation sedation | adult | 1–2 mcg/kg | IV/IO | not captured | standing | page 47 |
| Post-intubation sedation | peds | 1–2 mcg/kg | IV/IO | not captured | standing | page 47 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 93 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV/IO | not captured | standing | page 93 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 93 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 93 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | page 158 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | page 90 |
| Allergic reaction | peds | 0.25 mg | NEB | not captured | standing | page 90 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 90 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | page 90 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 111 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg/kg | IV/IO/IN | not captured | standing | page 157 |
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 157 |
| Mild to moderate pain | adult | 0.5–1 mg/kg | IV/IO/IM/IN | not captured | standing | page 173 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 30 mg | IO/IM/IN | not captured | standing | page 172 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | not captured | not captured | standing | page 95 |
| Other | adult | 5 mg | not captured | not captured | standing | page 103 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 20–40 mg | IO | not captured | standing | page 246 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 246 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IO | not captured | standing | page 64 |
| Wide-complex tachycardia | peds | 1 mg/kg | IO | not captured | standing | page 64 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV | not captured | standing | page 64 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | page 64 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 309 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 309 |
| Post-intubation sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 309 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 309 |
| Seizure | adult | 2 mg | IV/IO/IM | not captured | standing | page 114 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 114 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 112 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV | not captured | standing | page 112 |
| Wide-complex tachycardia | adult | 1 g | IV/IO | not captured | standing | page 69 |
| VF / pulseless VT | adult | 1 g | IV | not captured | standing | page 65 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV | not captured | standing | page 65 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IO/IM | not captured | standing | page 90 |
| Allergic reaction | peds | 2 mg/kg | IO/IM | not captured | standing | page 90 |
| Anaphylaxis | adult | 125 mg | IO/IM | not captured | standing | page 90 |
| Anaphylaxis | peds | 2 mg/kg | IO/IM | not captured | standing | page 90 |
| Asthma / bronchospasm | adult | 125 mg | IO/IM | not captured | standing | page 90 |
| Asthma / bronchospasm | peds | 2 mg/kg | IO/IM | not captured | standing | page 90 |
| COPD | adult | 125 mg | IO/IM | not captured | standing | page 111 |
| COPD | peds | 2 mg/kg | IO/IM | not captured | standing | page 111 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 157 |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 157 |
| Other | adult | 2–5 mg | IO | not captured | standing | page 70 |
| Other | peds | 0.1 mg/kg | IO | not captured | standing | page 70 |
| Post-intubation sedation | adult | 0.1 mg/kg | IO | not captured | standing | page 314 |
| Post-intubation sedation | peds | 0.1 mg/kg | IO | not captured | standing | page 314 |
| Seizure | adult | 0.1 mg/kg | IO/IM/IN | not captured | standing | page 113 |
| Seizure | peds | 0.1 mg/kg | IO/IM/IN | not captured | standing | page 113 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2 mg | IO | not captured | standing | page 316 |
| CHF / pulmonary edema | adult | 2 mg | IO | not captured | standing | page 316 |
| Mild to moderate pain | adult | 2–4 mg | IO/IM | not captured | standing | page 172 |
| Mild to moderate pain | peds | 0.05–0.1 mg/kg | IO/IM | not captured | standing | page 172 |
| Post-intubation sedation | adult | 2–4 mg | not captured | not captured | standing | page 316 |
| Post-intubation sedation | peds | 0.05–0.1 mg/kg | not captured | not captured | standing | page 316 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Bradycardia | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Cardiac arrest | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Cardiac arrest | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Hypotension / shock | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Hypotension / shock | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Other | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Other | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Respiratory distress | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
| Respiratory distress | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 107 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 52 |
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 52 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 66 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 96 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–4 mcg | IV/IO | not captured | standing | page 115 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM | not captured | standing | page 87 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM | not captured | standing | page 87 |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 87 |
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 87 |
| Nausea / vomiting | peds | 0.1 mg/kg (max 4 mg) | IV/IO/IM | not captured | standing | page 87 |
| Nausea / vomiting | peds | 0.1 mg/kg (max 4 mg) | IV/IO/IM | not captured | standing | page 87 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | page 87 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | page 87 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 24 g | PO | not captured | standing | page 93 |
| Hypoglycemia | peds | 24 g | PO | not captured | standing | page 93 |
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 94 |
| RSI induction | adult | 2 spray | IN | not captured | standing | page 27 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | peds | 0.5 mL | NEB | not captured | standing | page 105 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 47 |
| RSI induction | adult | 1–1.2 mg/kg | IV/IO | not captured | standing | page 39 |
| RSI induction | peds | 0.6 mg/kg | IV/IO | not captured | standing | page 39 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IO | not captured | standing | page 59 |
| Cardiac arrest | peds | 1 mEq/kg | IO | not captured | standing | page 59 |
| Other | adult | 1 mEq/kg | IO | not captured | standing | page 109 |
| Other | peds | 1 mEq/kg | IO | not captured | standing | page 109 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IO | not captured | standing | page 39 |
| RSI induction | peds | 2 mg/kg | IO | not captured | standing | page 39 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2000 mg | IV/IO | not captured | standing | page 242 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 242 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Post-intubation sedation | adult | 0.01–0.03 mg/kg | IV/IO | not captured | standing | page 47 |
| Post-intubation sedation | peds | 0.01–0.03 mg/kg | IV/IO | not captured | standing | page 47 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 39 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 39 |